Answers are grounded in this paper and cite their sources.
Bacillus thuringiensis is widely used as a biopesticide in forestry and agriculture, being able to produce potent species-specific insecticidal toxins and considered nonpathogenic to other animals. More recently, however, repeated observations are documenting the association of this microorganism with various infectious diseases in humans, such as food-poisoning-associated diarrheas, periodontitis, bacteremia, as well as ocular, burn, and wound infections. Similar to B. cereus, B. thuringiensis produces an array of virulence factors acting against mammalian cells, such as phosphatidylcholine- and phosphatidylinositol-specific phospholipase C (PC-PLC and PI-PLC), hemolysins, in particular hemolysin BL (HBL), and various enterotoxins. The contribution of some of these toxins to B. thuringiensis pathogenicity has been studied in animal models of infection, following intravitreous, intranasal, or intratracheal inoculation. These studies lead to the speculation that the activities of PC-PLC, PI-PLC, and HBL are responsible for most of the pathogenic properties of B. thuringiensis in nongastrointestinal infections in mammals. This review summarizes data regarding the biological activity, the genetic basis, and the structural features of these membrane-damaging toxins. This review summarizes data regarding B. thuringiensis toxins responsible for most of the pathogenic properties this microorganism may exert in non-gastrointestinal infections in mammals. This review summarizes data regarding B. thuringiensis toxins responsible for most of the pathogenic properties this microorganism may exert in non-gastrointestinal infections in mammals.
No takes yet. Share an insight, caveat, or question.
Celandroni et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: